Welcome to the Xagrid Product Information Section
This section of the website is specifically designed to provide healthcare professionals with useful up-to-date information about the essential thrombocythaemia treatment, Xagrid (anagrelide hydrochloride).
From prescribing information to key considerations for use, this regularly updated site will provide you with the background information you need about Xagrid.
Anagrelide hydrochloride is marketed by Shire as Xagrid in the EU, the EEA countries, Norway, Iceland, Liechtenstein and Switzerland.
If you are not a healthcare professional, click here.